Index · Artikel · Using AIDS drugs to prevent infection: a bargain?

Using AIDS drugs to prevent infection: a bargain?

2012-04-16 5
   
Advertisement
résuméCHICAGO Giving an AIDS-fighting drug to men who are at high risk of HIV infection would cost billions, but it might be worth it terms of reducing infection rates, U.S. researchers said on Monday. Since 2010, when a landmark study in the New England J
Advertisement

Using AIDS drugs to prevent infection: a bargain?


CHICAGO Giving an AIDS-fighting drug to men who are at high risk of HIV infection would cost billions, but it might be worth it terms of reducing infection rates, U.S. researchers said on Monday.

Since 2010, when a landmark study in the New England Journal of Medicine found that giving a daily dose of Gilead Sciences' Truvada to men who have sex with men can reduce HIV infection rates by 44 percent, researchers have been trying to work out how to make this treatment approach financially feasible.

Gilead is seeking permission for Truvada -- a combination of its HIV drugs Emtriva, also known as emtricitabine, and Viread, or tenofovir -- to be used as a form of "pre-exposure prophylaxis," often shortened to PrEP.

The drug is already approved to treat people infected with the human immunodeficiency virus that causes AIDS.

A prior study found that giving Truvada to all men who have sex with men -- who account for more than half of the estimated 56,000 new infections annually in the United States -- was too costly.

The latest study from a team at Stanford University estimates that giving a daily preventive dose of the drug to all U.S. men who have sex with men would cost $495 billion over 20 years in terms of the cost of drugs and healthcare visits, the team reported in the Annals of Internal Medicine.

And giving the drug to healthy men to prevent a future infection might come at the expense of treating people who are already infected with HIV, the virus that causes AIDS, they said.

Instead, the team looked specifically at men who are high risk of developing HIV -- those who have five or more sexual partners a year.

If just 20 percent of these high-risk individuals took the drug it could prevent 41,000 new infections over a period of 20 years, at a cost of about $16.6 billion during that period, the team found.

By targeting this high-risk group, the team estimates the treatment could prevent twice as many infections as it could if given to 20 percent of the general population of men who have sex with men, and it would offer a better value.

"Use in high-risk men who have sex with men would provide substantial health benefits at a lower cost, although the budgetary effect would still be sizeable," Jessie Juusola, a PhD. candidate at Stanford, and colleagues wrote in the Annals of Internal Medicine.

The team said the findings can help shape doctors and policymakers' decisions about which patients should get the drug.

An estimated 1.2 million Americans have HIV, according to the Centers for Disease Control and Prevention.

In preliminary guidelines issued last year, the CDC said only high-risk gay and bisexual men should use a daily AIDS pill to protect themselves from the virus.

An FDA advisory panel is expected to consider in mid-May whether to allow use of the drug as a way to prevent HIV infection in healthy people.

(Reporting By Julie Steenhuysen; Editing by Andrew Hay)

  • Using AIDS drugs to prevent infection: a bargain?

    Using AIDS drugs to prevent infection: a bargain?
    CHICAGO Giving an AIDS-fighting drug to men who are at high risk of HIV infection would cost billions, but it might be worth it terms of reducing infection rates, U.S. researchers said on Monday. Since 2010, when a landmark study in the New England J
    2012-04-16 AIDSDRUGS
  • U.S. rolls back AIDS drug prevention trial in Botswana

    U.S. rolls back AIDS drug prevention trial in Botswana
    WASHINGTON U.S. officials said on Thursday they will give up on a trial in Botswana that was trying to show whether it is possible to prevent HIV infections by taking a daily pill because too few people are being infected. There are also problems kee
    2009-12-18 AIDSTRIAL
  • HIV numbers hit new high as AIDS drugs save lives

    HIV numbers hit new high as AIDS drugs save lives
    LONDON More people than ever are living with the AIDS virus but this is largely due to better access to drugs that keep HIV patients alive and well for many years, the United Nations AIDS program (UNAIDS) said on Monday. In its annual report on the p
    2011-11-21 AIDSGLOBALUNAIDS
  • U.N. says millions still lack access to AIDS drugs

    U.N. says millions still lack access to AIDS drugs
    LONDON More than half of the 9.5 million people who need AIDS drugs cannot get them and 33 million people across the world are still infected with the virus that causes it, a United Nations report said on Wednesday. Access to drugs, counseling and te
    2009-09-30 AIDSPROGRESS
  • AIDS drug cocktails saving lives: study

    AIDS drug cocktails saving lives: study
    NEW YORK (Reuters Health) - Taking a cocktail of powerful AIDS drugs appears to have cut the average death rate by half in a group of people infected with HIV, the virus that causes AIDS, who were followed for an average of more than three years. In
    2010-01-04 AIDSCOCKTAILS
  • NIH joins patent pool for AIDS drugs

    NIH joins patent pool for AIDS drugs
    LONDON The United States National Institutes of Health said on Thursday it will share intellectual property rights on some AIDS drugs in a patent pool designed to make treatments more widely available to the poor. The NIH is the first research instit
    2010-09-30 AIDSDRUGSPATENTS
  • Generics deal cuts cost of AIDS drugs for poor

    Generics deal cuts cost of AIDS drugs for poor
    LONDON A global health development partnership said on Tuesday it had secured price reductions on key AIDS drugs for HIV-positive patients in poorer countries. The Boston-based Clinton Health Access Initiative, Geneva's UNITAID, and the British gover
    2011-05-18 AIDSDRUGS
  • AIDS drugs can cause premature ageing: study

    AIDS drugs can cause premature ageing: study
    LONDON A class of generic AIDS drugs often used to treat HIV in Africa and other poor regions can cause premature aging and lead to age-related illnesses such as heart disease and dementia, scientists said on Sunday. In a study in the journal Nature
    2011-06-26 DRUGSHIVAGEING
  • Children with HIV in Asia suffer resistance to AIDS drugs

    Children with HIV in Asia suffer resistance to AIDS drugs
    HONG KONG Teenagers in Asia receiving treatment for HIV are showing early signs of osteoporosis and children as young as five are becoming resistant to AIDS drugs, an anti-AIDS group said on Thursday, urging more attention be given to young HIV patie
    2011-12-01 CHILDRENAIDSASIA
  • Some South African clinics running short of HIV/AIDS drugs: MSF

    Some South African clinics running short of HIV/AIDS drugs: MSF
    JOHANNESBURG One in five South African clinics are running short of life-saving HIV/AIDS drugs, affecting nearly half a million people and undermining the success of the world's largest treatment program, medical charities said on Thursday. With abou
    2013-11-28 AIDSSAFRICA
  • We can't beat cancer with drugs alone; prevention crucial: WHO

    We can't beat cancer with drugs alone; prevention crucial: WHO
    LONDON Governments must make better use of vaccines and preventative public health policies in the fight against cancer as treatment alone cannot stem the disease, a World Health Organization (WHO) agency said on Monday. The WHO's International Agenc
    2014-02-03 CANCER
  • GlaxoSmithKline unit joins patent pool for AIDS drugs

    GlaxoSmithKline unit joins patent pool for AIDS drugs
    LONDON GlaxoSmithKline's HIV/AIDS drugs business is to share intellectual property rights on children's medicine in a patent pool designed to make treatments more widely available in poor countries. ViiV Healthcare, majority-owned by GSK, is the seco
    2013-02-27 AIDSDRUGSPATENTS
  • New U.S. AIDS policy targets prevention

    New U.S. AIDS policy targets prevention
    WASHINGTON A new domestic AIDS policy rolled out by the White House on Tuesday asks states and federal agencies to find ways to cut new infections by 25 percent, get more patients treated quickly and educate Americans about the deadly and incurable v
    2010-07-13 AIDSUSA
  • HIV/AIDS drug puzzle cracked

    HIV/AIDS drug puzzle cracked
    LONDON Scientists say they have solved a crucial puzzle about the AIDS virus after 20 years of research and that their findings could lead to better treatments for HIV. British and U.S. researchers said they had grown a crystal that enabled them to s
    2010-02-01 AIDSHIVENZYME
  • Millions will die if India stops AIDS drugs: U.N.

    Millions will die if India stops AIDS drugs: U.N.
    NEW DELHI Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday. The EU and India
    2011-07-05 AIDSINDIADRUGS
  • Getting personal: New tests aid drug performance

    Getting personal: New tests aid drug performance
    CHICAGO Better diagnostic tests and pressure to lower healthcare costs may finally usher in the era of personalized medicine, in which patients get drugs tailored to their genetic makeup, a new report suggests. Personalized medicine has been a resear
    2009-07-31 DRUGSDIAGNOSTICS
  • Cancer drug could prevent blindness in preemies

    Cancer drug could prevent blindness in preemies
    NEW YORK (Reuters Health) - The cancer drug Avastin could help prevent blindness in a group of premature babies who were born before their eyes developed completely, according to a new study. About 50,000 people worldwide are blind -- among them sing
    2011-02-17 PREEMIESBLINDNESS
  • GSK raises bet on AIDS drug with new Shionogi deal

    GSK raises bet on AIDS drug with new Shionogi deal
    LONDON/TOKYO GlaxoSmithKline has raised its bet on a promising drug for HIV/AIDS by redrawing a deal with Japan's Shionogi which gives it a much bigger economic interest in the new product. Dolutegravir, a once-daily drug that has performed strongly
    2012-10-29 HIVGSKShionogi
  • AbbVie adds children's AIDS drugs to shared patent pool

    AbbVie adds children's AIDS drugs to shared patent pool
    LONDON U.S. drugmaker AbbVie has added two HIV medicines for children to a shared patent pool in an initiative that should speed the development of cheap new pediatric formulations for use in poor countries. It is the latest win for the non-profit Me
  • Marinol (Dronabinol) - HIV / AIDS Drug Information

    Marinol (Dronabinol) - HIV / AIDS Drug Information
    Marinol (Dronabinol) ist ein verschreibungspflichtiges Medikament von Marihuana abgeleitet sind, die früher häufig bei Menschen mit HIV-assoziierter Wasting-Syndrom verschrieben wurde. Während seine Verwendungen zu denen von medizinischem Marihuana ä

TOP

  • Day/
  • Week/
  • Original/
  • Recommand

Updated

  • Irlands Renommierte Oatmeal

    Irlands Renommierte Oatmeal
    Foto von gebissene Word / Flickr CC Um einen Eindruck von der Geschichte zur Kenntnis nehmen , dass die Mühle , in der diese Macroom Haferflocken gemacht wurde in den 1800er Jahren gebaut, damals , als die Cork Butter Wechsel in der Nähe der Höhe sei
  • Hat jemand in der Lage gewesen, für Repliva oder Pruvate Rezept zu füllen?

    Ich kann nicht eine Apotheke in der Lage ist Repliva oder Pruvate zu bestellen. Ich habe mehrere verschiedene Antworten bekommen. ----schneiden---- In Antwort auf die Marvell bei 2009-10-07 01.24 Es muss ein Problem mit Versorgung sein, da es um eine
  • Gibt es eine Korrelation zwischen der Konzentration und Epilepsie? wenn ja, was?

    Ich habe Symptome ADD, und ich bin einen epileptischen. Sind diese beiden Erkrankungen oft verbunden oder könnte die andere Störung verursachen? ----schneiden---- In Antwort auf 2010-04-18 16:11 Uhr in suzanne66 Ja, haben viele Studien gezeigt, dass
  • Werde ich nach 3 Wochen Gebrauch von Opiaten süchtig werden?

    Ich habe Einnahme über einen Tag der roxie 30mg ... seine seit 3 ​​Wochen 120mg. werde ich schlecht W / d's durchlaufen? ----schneiden---- In Antwort auf phyl56 bei 2010-05-19 00.16 Ich bin kein Experte, aber hatten Betäubungsmittel zu verwenden, um
  • Hydrochinon von Chinin abgeleitet?

    Ich habe eine Reaktion auf eine Chinin-basierte Arthritis Medikament hatte und wollen eine ähnliche Reaktion zu vermeiden. ----schneiden---- In Antwort auf 2010-06-28 02.31 bis suzanne66 Nein - Hydrochinon ist eine Art von Phenol. Obwohl ihre Namen k
  • Ein Leben auf dem Grill (und ein Labor Day Rezept)

    Ein Leben auf dem Grill (und ein Labor Day Rezept)
    Grillworks Inc Ich mag Feuer. Als Kind verbrannte ich unser Haus fast in jedem der aufeinander folgenden Ländern nach unten wir nach Hause genannt. Ich spielte mit Streichhölzern in Paris und Buenos Aires, und sicherlich in London hätte, wenn ich nic
  • Estrace wie kann ich auf Linie zu kaufen?

    Kann ich von Ihrer Website kaufen? Wie kann ich auf Linie kaufen? Dies ist ein Medikament, ich jeden Tag nehmen. Ich habe nicht mehr Krankenversicherung so muss ich auf Linie zu finden. HILFE! ----schneiden---- In Antwort auf 2010-10-25 18:48 Uhr in
  • Charles River Labs sucht Unterstützung für Fusion mit WuXi

    Charles River Labs sucht Unterstützung für Fusion mit WuXi
    Mit Blick auf Opposition über seine $ 1600000000 Fusion mit WuXi Pharmatech, Charles River Laboratories International umwirbt Unterstützung für den Deal mit einem neuen Investor Präsentation und positive Reaktionen von Kunden. Mit Blick auf polstern
  • Ich habe für 6 Monate und Erfahrung diarea Einnahme Victoza, ist das normal?

    Ich nehme Metformin, die ich bis 1000 von 2000 reduziert haben, wie Krankenschwester Victoza gesagt wurde, könnte nt die Ursache sein ----schneiden---- In Antwort auf Tonka8561 bei 2011-05-29 10.51 Mein Verständnis, dass die maximale Dosis für Metfor
  • Wake Forest medizinische Schule Namen der UAB Abraham neuen Dekan

    Wake Forest medizinische Schule Namen der UAB Abraham neuen Dekan
    Wake Forest University 's neue medizinische Fakultät Dekan an der University of Alabama in Birmingham kommen. Dr. Edward Abraham, Vorsitzender der Abteilung für Medizin an der UAB, nimmt seinen neuen Posten in Winston-Salem, North Carolina wirksam Au